161 related articles for article (PubMed ID: 6705283)
1. Effects of dobutamine on left ventricular performance and myocardial metabolic demands in patients with ischemic heart disease.
Côté P; Bourassa MG; Tubau JF; Enjalbert M; Vandormael M
Clin Cardiol; 1984 Jan; 7(1):14-22. PubMed ID: 6705283
[TBL] [Abstract][Full Text] [Related]
2. Dobutamine in chronic ischemic heart failure: alterations in left ventricular function and coronary hemodynamics.
Bendersky R; Chatterjee K; Parmley WW; Brundage BH; Ports TA
Am J Cardiol; 1981 Sep; 48(3):554-8. PubMed ID: 7270460
[TBL] [Abstract][Full Text] [Related]
3. Improved hemodynamic function and mechanical efficiency in congestive heart failure with sodium dichloroacetate.
Bersin RM; Wolfe C; Kwasman M; Lau D; Klinski C; Tanaka K; Khorrami P; Henderson GN; de Marco T; Chatterjee K
J Am Coll Cardiol; 1994 Jun; 23(7):1617-24. PubMed ID: 8195522
[TBL] [Abstract][Full Text] [Related]
4. Effects of low-dose dobutamine on coronary hemodynamics, myocardial metabolism, and anginal threshold in patients with coronary artery disease.
Pacold I; Kleinman B; Gunnar R; Loeb HS
Circulation; 1983 Nov; 68(5):1044-50. PubMed ID: 6616788
[TBL] [Abstract][Full Text] [Related]
5. Comparison of the effects of amrinone and dobutamine on hemodynamics and myocardial oxygen balance in dogs with experimental left ventricular failure.
Fujigaki T; Nakamura H; Fukui S; Miyako M; Haseba S; Gotoh Y
J Cardiothorac Anesth; 1989 Aug; 3(4):433-40. PubMed ID: 2520916
[TBL] [Abstract][Full Text] [Related]
6. Dobutamine and dopamine after cardiac surgery: greater augmentation of myocardial blood flow with dobutamine.
Fowler MB; Alderman EL; Oesterle SN; Derby G; Daughters GT; Stinson EB; Ingels NB; Mitchell RS; Miller DC
Circulation; 1984 Sep; 70(3 Pt 2):I103-11. PubMed ID: 6744557
[TBL] [Abstract][Full Text] [Related]
7. Comparative effects of dobutamine and corwin, a beta 1-adrenergic partial agonist, in experimental left ventricular failure.
Vik-Mo H; Yasay G; Maroko PR; Ribeiro LG
J Cardiovasc Pharmacol; 1985; 7(4):784-90. PubMed ID: 2410722
[TBL] [Abstract][Full Text] [Related]
8. Dobutamine and cardiac oxygen balance in patients following myocardial revascularization.
Sethna DH; Gray RJ; Moffitt EA; Bussell JA; Raymond MJ; Conklin CM; Matloff JM
Anesth Analg; 1982 Nov; 61(11):917-20. PubMed ID: 7137609
[TBL] [Abstract][Full Text] [Related]
9. Myocardial metabolism and ventricular function following cold potassium cardioplegia.
Fremes SE; Weisel RD; Mickle DA; Ivanov J; Madonik MM; Seawright SJ; Houle S; McLaughlin PR; Baird RJ
J Thorac Cardiovasc Surg; 1985 Apr; 89(4):531-46. PubMed ID: 3872382
[TBL] [Abstract][Full Text] [Related]
10. [Hemodynamic effects of dobutamine in patients with severe low-output heart failure (author's transl)].
Parodi O; Crea F; Pesola A; Distante A; Chierchia S; Moscarelli E; L'Abbate A; Maseri A
G Ital Cardiol; 1980; 10(9):1141-7. PubMed ID: 7193152
[TBL] [Abstract][Full Text] [Related]
11. Consequences of regional inotropic stimulation of ischemic myocardium on regional myocardial blood flow and function in anesthetized swine.
Schulz R; Miyazaki S; Miller M; Thaulow E; Heusch G; Ross J; Guth BD
Circ Res; 1989 Jun; 64(6):1116-26. PubMed ID: 2720914
[TBL] [Abstract][Full Text] [Related]
12. Effect of intravenous prenalterol on haemodynamics and myocardial lactate extraction in patients with left ventricular failure.
Kupper W; Schütt M; Bleifeld W
Acta Med Scand Suppl; 1982; 659():287-98. PubMed ID: 6127895
[TBL] [Abstract][Full Text] [Related]
13. Myocardial energetics and efficiency in patients with idiopathic cardiomyopathy: response to dobutamine and amrinone.
Sundram P; Reddy HK; McElroy PA; Janicki JS; Weber KT
Am Heart J; 1990 Apr; 119(4):891-8. PubMed ID: 2321508
[TBL] [Abstract][Full Text] [Related]
14. Hemodynamic and myocardial energetic changes induced by the new cardiotonic agent, AR-L 115, in patients with coronary artery disease.
Thormann J; Kramer W; Schlepper M
Am Heart J; 1982 Dec; 104(6):1294-302. PubMed ID: 7148647
[TBL] [Abstract][Full Text] [Related]
15. Dobutamine and hydralazine: comparative influences of positive inotropy and vasodilation on coronary blood flow and myocardial energetics in nonischemic congestive heart failure.
Magorien RD; Unverferth DV; Brown GP; Leier CV
J Am Coll Cardiol; 1983 Feb; 1(2 Pt 1):499-505. PubMed ID: 6826960
[TBL] [Abstract][Full Text] [Related]
16. Systemic and coronary effects of intravenous milrinone and dobutamine in congestive heart failure.
Grose R; Strain J; Greenberg M; LeJemtel TH
J Am Coll Cardiol; 1986 May; 7(5):1107-13. PubMed ID: 3958369
[TBL] [Abstract][Full Text] [Related]
17. Effects of dobutamine versus insulin on cardiac performance, myocardial oxygen demand, and total body metabolism after coronary artery bypass grafting.
Hiesmayr M; Haider WJ; Grubhofer G; Heilinger D; Keznickl FP; Mares P; Rajek AM; Coraim F; Semsroth M
J Cardiothorac Vasc Anesth; 1995 Dec; 9(6):653-8. PubMed ID: 8664455
[TBL] [Abstract][Full Text] [Related]
18. Conditioning effects of chronic infusions of dobutamine. Comparison with exercise training.
Liang C; Tuttle RR; Hood WB; Gavras H
J Clin Invest; 1979 Aug; 64(2):613-9. PubMed ID: 457872
[TBL] [Abstract][Full Text] [Related]
19. Comparison of dobutamine and dopamine in treatment of severe heart failure.
Stoner JD; Bolen JL; Harrison DC
Br Heart J; 1977 May; 39(5):536-9. PubMed ID: 324501
[TBL] [Abstract][Full Text] [Related]
20. Coronary vasodilating action of dobutamine in patients with idiopathic dilated cardiomyopathy.
Dubois-Randé JL; Merlet P; Duval-Moulin AM; Adnot S; Saal JP; Chabrier E; Castaigne A; Geschwind H
Am Heart J; 1993 May; 125(5 Pt 1):1329-36. PubMed ID: 8480585
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
